4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit Hilton Boston Back Bay, Boston
Lipid-based nanoparticles are evolving-faster, safer and more precise than ever. With traditional LNPs struggling to reach tissues beyond the liver, the industry is doubling down on next generation technologies for extra-hepatic. In 2024 alone, Novo Nordisk invested $600M in NanoVation to push genetic medicines further, while Nanite and Saliogen joined forces to pioneer non-viral, lung-targeting nanoparticles.
Formerly known as the Next Gen Lipid-Based Nanoparticle Delivery Summit, the summit is the only industry-dedicated event laser-focused on extrahepatic targeting, delivery efficiency and scalable manufacturing for mRNA, siRNA, DNA and gene therapies.
Join 80+ delivery experts, CXOs and leading scientists from AstraZeneca, Novo Nordisk, Takeda, Orbital Therapeutics and more for three jam-packed days in Boston this June. Get exclusive insights, real-world case studies and cutting-edge strategies to supercharge your lipid-based delivery vehicles beyond the liver and into the next generation.
⌛ Event Dates & Venue
👨👧👦 Social Networks
💸 Website & Tickets
Go to Event Website Conference + Workshop Day - Pharma and Biotech Pricing: USD 4197.00, Conference Only - Pharma and Biotech Pricing: USD 2999.00, Conference + Workshop Day - Solution Provider Pricing: USD 5097.00, Conference Only - Solution Provider Pricing: USD 3699.00, Conference + Workshop Day - Academic and Research Pricing: USD 3597.00, Conference Only - Academic and Research Pricing: USD 2599.00
Advertisements